SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Mapping the Functional Assessment of Cancer Therapy - Breast (FACT-B) to the 5-level EuroQoL group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a Multi-ethnic Asian population
14 references·0 citing·45 second hop
Mapping the Functional Assessment of Cancer Therapy - Breast (FACT-B) to the 5-level EuroQoL group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a Multi-ethnic Asian population (2014)Mapping the Functional Assessment of Canc…Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database (2013)Review of studies mapping fro…Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments (2013)Mapping to Obtain EQ-5D Utili…Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)Interim Scoring for the EQ-5D…Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate? (2010)Analysis of Health Utility Da…A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures (2009)A review of studies mapping (…Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index (2008)Mapping the English and Chine…A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes (2008)A comparison of EQ-5D index s…Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients (2007)Mapping FACT-P and EORTC QLQ-…Evaluating Equivalency Between Response Systems (2007)Evaluating Equivalency Betwee…Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer (2007)Estimation of minimally impor…Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample (2006)Mapping the EQ-5D Index from …Estimating an EQ‐5D population value set: the case of Japan (2002)Estimating an EQ‐5D populatio…A Comparison of Methods for Analyzing Health-Related Quality-of-Life Measures (2002)A Comparison of Methods for A…Observer error in grading performance status in cancer patients (1999)Observer error in grading per…EuroQol - a new facility for the measurement of health-related quality of life (1990)Methods for the Economic Evaluation of Health Care Programmes (2005)Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available) (2008)Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? (2009)Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome (2009)Theory of games and economic behavior (2019)Scientific problems in clinical scales, as demonstrated in the karnofsky index of performance status (1979)Performance status assessment in cancer patients. An inter-observer variability study (1993)Family Physician Involvement in Cancer Care Follow-up: The Experience of a Cohort of Patients With Lung Cancer (2010)Patient, Primary Care Physician and Specialist Expectations of Primary Care Physician Involvement in Cancer Care (2011)The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers (2015)Limited-dependent and qualitative variables in econometrics (1983)Quality of life and pharmacoeconomics in clinical trials (1996)Quality of life and pharmacoeconomics in clinical trials (1996)A Comparison of the Direct Costs and Cost Effectiveness of Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions (2004)Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample (2014)Modeling Valuations for EuroQol Health States (1997)EQ-SD: a measure of health status from the EuroQol Group (2001)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study (2012)EQ-5D and the EuroQol Group: Past, Present and Future (2017)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)EuroQol: the current state of play (1996)The estimation of a preference-based measure of health from the SF-36 (2002)Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D (2005)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)Valuation of the Child Health Utility 9D Index (2012)Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey (2014)Cost-Effectiveness in Health and Medicine (1996)Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System (2002)Smoking and health-related quality of life in English general population: implications for economic evaluations (2012)Sexual orientation-related disparities in employment, health insurance, healthcare access and health-related quality of life: a cohort study of US male and female adolescents and young adults (2018)Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings (2021)Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review (2006)The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration (2015)Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement (2018)An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values (2019)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations (2015)The minimum clinically important difference for EQ-5D index: a critical review (2014)Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer (2016)South Korean Time Trade-Off Values for EQ-5D Health States: Modeling with Observed Values for 101 Health States (2009)The EQ-5D-5L valuation study in Korea (2016)Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries (2018)
this work references cited by second hop

References

  • 2012Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets2,153 cited
  • 2007Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer931 cited
  • 2002Estimating an EQ‐5D population value set: the case of Japan564 cited
  • 2009A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures517 cited
  • 2013Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments263 cited
  • 2006Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample249 cited
  • 2010Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?170 cited
  • 2013Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database153 cited
  • 1999Observer error in grading performance status in cancer patients141 cited
  • 2002A Comparison of Methods for Analyzing Health-Related Quality-of-Life Measures121 cited
  • 2007Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients87 cited
  • 2008A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes69 cited
  • 2007Evaluating Equivalency Between Response Systems66 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2008Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index59 cited
  • Cited by

    No citing works inside the corpus for this window.